Abstract: A pharmaceutical waste disposal assembly (10) for disposing of one or more of fluid pharmaceutical waste and solid pharmaceutical waste includes a first waste receiver (614) and a receiver retainer (16). The first waste receiver (614) includes a first receiver body (621) having a first body access (621BA). Additionally, the pharmaceutical waste moves in a first direction (695C) toward the first body access (621BA) through which the pharmaceutical waste is directly received by the first receiver body (621). The receiver retainer (16) substantially encloses the first waste receiver (614). Further, the first waste receiver (614) is removable from the receiver retainer (16). Moreover, one of the first waste receiver (614) and the receiver retainer (16) includes a first waste guide (667A) that guides the pharmaceutical waste in a second direction (695A) away from the first body access (621BA) and in the first direction (695C) toward the first body access (621BA).

Abstract: A cancellation feature (2203) for a pharmaceutical waste disposal assembly (10) having a first surface (2201) and a second surface (2202) can include a first cancellation member (2204) that is secured to the first surface (2204) and a second cancellation member (2205) that is secured to the second surface (2205). The second cancellation member (2205) automatically moves from a pre-engaged configuration that allows engagement with the first cancellation member (2204) to a post-engaged configuration that inhibits engagement with the first cancellation member (2204). The automatic movement occurs after engagement and/or during disengagement between the second cancellation member (2205) and the first cancellation member (2204). The first surface (2201) can form a portion of a receiver that receives pharmaceutical waste, and the second surface (2202) can form a portion of a receiver retainer that retains the receiver.

Abstract: A pharmaceutical waste disposal assembly (1810) for disposing of sharps and one or more of fluid pharmaceutical waste and solid pharmaceutical waste includes a receiver assembly (1851) having a sharps receiver (1815), a waste receiver (1812), and a receiver retainer (1816). The sharps receiver (1815) receives sharps. The sharps receiver (1815) includes a sharps receiver body (1823) that defines a sharps region (1827C). The waste receiver (1812) receives one of fluid pharmaceutical waste and solid pharmaceutical waste. The waste receiver (1812) includes a waste receiver body (1819) that defines a waste region (1827A) that is independent of the sharps region (1827C). The receiver retainer (1816) receives the sharps receiver (1815) and the waste receiver (1812). The sharps receiver body (1823) and the waste receiver body (1819) are positioned substantially adjacent to one another within the receiver retainer (1816).

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste comprises a first receiver body (19) and a first reaction agent (287). The first receiver body (19) receives the pharmaceutical waste. The first receiver body (19) includes a receiver bottom (283). The first reaction agent (287) is positioned within the first receiver body (19) and spaced apart from the receiver bottom (283). The pharmaceutical waste reacts with the first reaction agent (287) to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body (19) can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent (287) may include one or more of a denaturant, an emetic and a tittering agent. For example, the first reaction agent (287) may include one or more of quinine, ipecac and denatonium benzoate.

Abstract: A cancellation feature (2203) for a pharmaceutical waste disposal assembly (10) having a first surface (2201) and a second surface (2202) can include a first cancellation member (2204) that is secured to the first surface (2204) and a second cancellation member (2205) that is secured to the second surface (2205). The second cancellation member (2205) automatically moves from a pre-engaged configuration that allows engagement with the first cancellation member (2204) to a post-engaged configuration that inhibits engagement with the first cancellation member (2204). The automatic movement occurs after engagement and/or during disengagement between the second cancellation member (2205) and the first cancellation member (2204). The first surface (2201) can form a portion of a receiver that receives pharmaceutical waste, and the second surface (2202) can form a portion of a receiver retainer that retains the receiver.

Abstract: A pharmaceutical waste disposal assembly (1810) for disposing of sharps and one or more of fluid pharmaceutical waste and solid pharmaceutical waste includes a receiver assembly (1851) having a sharps receiver (1815), a waste receiver (1812), and a receiver retainer (1816). The sharps receiver (1815) receives sharps. The sharps receiver (1815) includes a sharps receiver body (1823) that defines a sharps region (1827C). The waste receiver (1812) receives one of fluid pharmaceutical waste and solid pharmaceutical waste. The waste receiver (1812) includes a waste receiver body (1819) that defines a waste region (1827A) that is independent of the sharps region (1827C). The receiver retainer (1816) receives the sharps receiver (1815) and the waste receiver (1812). The sharps receiver body (1823) and the waste receiver body (1819) are positioned substantially adjacent to one another within the receiver retainer (1816).

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of one or more of fluid pharmaceutical waste and solid pharmaceutical waste includes a first waste receiver (614) and a receiver retainer (16). The first waste receiver (614) includes a first receiver body (621) having a first body access (621BA). Additionally, the pharmaceutical waste moves in a first direction (695C) toward the first body access (621BA) through which the pharmaceutical waste is directly received by the first receiver body (621). The receiver retainer (16) substantially encloses the first waste receiver (614). Further, the first waste receiver (614) is removable from the receiver retainer (16). Moreover, one of the first waste receiver (614) and the receiver retainer (16) includes a first waste guide (667A) that guides the pharmaceutical waste in a second direction (695A) away from the first body access (621BA) and in the first direction (695C) toward the first body access (621BA).